| Title : The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors - Grossberg_2013_CNS.Drugs_27_469 |
| Author(s) : Grossberg GT , Manes F , Allegri RF , Gutierrez-Robledo LM , Gloger S , Xie L , Jia XD , Pejovic V , Miller ML , Perhach JL , Graham SM |
| Ref : CNS Drugs , 27 :469 , 2013 |
| Abstract : |
| PubMedSearch : Grossberg_2013_CNS.Drugs_27_469 |
| PubMedID: 23733403 |
| Title : [Treatment of Alzheimer's Disease cognitive symptoms] - Abel_2008_Vertex_19 Suppl_39 |
| Author(s) : Abel C , Allegri RF , Garau L , Genovese O , Mangone CA |
| Ref : Vertex , 19 Suppl :39 , 2008 |
| Abstract : |
| PubMedSearch : Abel_2008_Vertex_19 Suppl_39 |
| PubMedID: 18392212 |
| Title : [Mild cognitive impairment. Survey of attitudes of specialists and general physicians. mild] - Serrano_2007_Medicina.(B.Aires)_67_19 |
| Author(s) : Serrano CM , Allegri RF , Caramelli P , Taragano FE , Camera L |
| Ref : Medicina (B Aires) , 67 :19 , 2007 |
| Abstract : |
| PubMedSearch : Serrano_2007_Medicina.(B.Aires)_67_19 |
| PubMedID: 17408016 |